Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
81.18
+2.84 (3.63%)
At close: Jun 26, 2026, 4:00 PM EDT
82.01
+0.83 (1.02%)
After-hours: Jun 26, 2026, 7:36 PM EDT
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,402 employees as of December 31, 2025. The number of employees increased by 333 or 31.15% compared to the previous year.
Employees
1,402
Change (1Y)
333
Growth (1Y)
31.15%
Revenue / Employee
$754,772
Profits / Employee
-$233,222
Market Cap
13.42B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Genmab | 3,088 |
| Jazz Pharmaceuticals | 2,890 |
| Axsome Therapeutics | 1,220 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
IONS News
- 2 days ago - Ionis Pharmaceuticals price target raised to $130 from $125 at H.C. Wainwright - TheFly
- 2 days ago - Ionis Pharmaceuticals enters zilganersen license agreement with Recordati - TheFly
- 3 days ago - Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S. - Business Wire
- 3 days ago - Ionis Pharmaceuticals price target raised to $75 from $74 at Goldman Sachs - TheFly
- 3 days ago - Ionis Pharmaceuticals Transcript: FDA announcement - Transcripts
- 3 days ago - Ionis Pharmaceuticals Slides: FDA announcement - Filings
- 3 days ago - Ionis Pharmaceuticals Press release: FDA announcement - Filings
- 3 days ago - FDA approves Ionis’ Tryngolza as adjunct to diet to reduce triglycerides - TheFly